Skip to main content
profile image
Selected Works of Shawn Spencer
Article
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
BJUI (2013)
  • William L. Dahut, National Institutes of Health
  • Ravi A. Madan, National Institutes of Health
  • Joyson J. Karakunnel, National Institutes of Health
  • David Adelberg, National Institutes of Health
  • James L. Gulley, National Institutes of Health
  • Ismail B. Turkbey, National Institutes of Health
  • Cindy H. Chau, National Institutes of Health
  • Shawn D. Spencer, National Institutes of Health
  • Marcia Mulquin, National Institutes of Health
  • John Wright, National Institutes of Health
  • Howard L. Parnes, National Institutes of Health
  • Seth M. Steinberg, National Institutes of Health
  • Peter L. Choyke, National Institutes of Health
  • William D. Figg, National Institutes of Health
Link
Disciplines
Publication Date
January 6, 2013
DOI
10.1111/j.1464-410X.2012.11667.x
Citation Information
William L. Dahut, Ravi A. Madan, Joyson J. Karakunnel, David Adelberg, et al.. "Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer." BJUI Vol. 111 Iss. 8 (2013) p. 1269 - 1280
Available at: http://works.bepress.com/shawn-spencer/10/